"
Team:EPF-Lausanne/Our Project/TetR mutants/Conclusion
From 2011.igem.org
(Difference between revisions)
| Line 14: | Line 14: | ||
| <html> <a href="http://partsregistry.org/Part:BBa_K613013"> BBa_K613013</a> </html> | | <html> <a href="http://partsregistry.org/Part:BBa_K613013"> BBa_K613013</a> </html> | ||
| same | | same | ||
| - | | | + | | higher |
| altered | | altered | ||
|- | |- | ||
Revision as of 03:36, 22 September 2011
In Vivo & In Vitro Outline
In vitro Main | Why TetR? | Mutant TetRs | MITOMI Data | In-vivo & In-vitro outline
For some of the TetR mutants, we managed to have both an in vitro and in vivo characterization. The results are available in the table below.
| Mutant | Biobrick number | Affinity compared to WT - in vivo | Affinity compared to WT - MITOMI | ATC repression |
|---|---|---|---|---|
| V36F | BBa_K613013 | same | higher | altered |
| V36F W43S | BBa_K613014 | same | not tested | altered |
| E37A W43S T141A | BBa_K613015 | same | altered | |
| P39K | BBa_K613016 | no affinity | normal | |
| Y42F K108E | BBa_K613018 | reduced | normal | |
| P39Q Y42M | BBa_K613019 | no affinity | not tested | normal |
The MITOMI results can be found here. The in vivo characterizations are on this page.
